SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding ...

It's common for clinical-stage biotech companies to post net losses, but the market wasn't forgiving of this one's latest.

Recursion reported second-quarter revenue of $19.22 million, beating analyst estimates of $16.23 million, according to ...

Guidance remains unchanged, with management projecting "over $100 million in partnership inflows by the end of 2026" and targeting a cash burn below $390 million in 2026. The company anticipates a ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Tuesday reported a loss of $171.9 million in its second quarter. On a per-share basis, the Salt Lake City-based ...

Your donation helps to fund strategic litigation, advocacy, and organizing needed to take on profiling and surveillance, ...

APL researchers have demonstrated that a quantum algorithm can be used to speed up an information analysis task that classical computers struggle to perform.

Figma just went public and could be the biggest IPO of the year. Here's what you need to know.

Daily tracking results are collected via telephone surveys of 300 likely voters per night and reported on a five-day rolling average basis.

After a tremendous 2025 UFL season, a handful of star players have signed contracts with NFL teams. Here's who's on the move.

The Rasmussen Reports daily Presidential Tracking Poll for Tuesday shows that 48% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-one percent (51%) disapprove. The ...